Results 91 to 100 of about 13,238 (216)
ABSTRACT Self‐reported adverse events following first and second recombinant zoster vaccination (RZV) doses in older adults (n = 41,069) collected through AusVaxSafety were analysed. Adverse event rates were higher following Dose 2 (54%; 95% CI, 53%–54%) than after Dose 1 (45%; 95% CI, 45%–46%), particularly with 3–6‐ and 7–9‐month dose intervals ...
Lucy Dawes +3 more
wiley +1 more source
Safety and reactogenicity of COVID-19 vaccines
The Australian Government has detailed a national rollout strategy for the delivery of COVID-19 vaccines. In the Phase 1a, vaccines will be available to quarantine and border workers, priority sub-groups of frontline health workers, and aged care and ...
Marnie, C., Peters, M.
core
This review highlights recent advances in engineering messenger RNA (mRNA)‐lipid nanoparticles (LNPs) to cross the ageing blood–brain barrier and target neurodegenerative diseases. It outlines design principles, delivery routes, and translational challenges, charting a roadmap towards clinical application of mRNA‐LNP therapeutics for neurodegenerative ...
Abdel Ali Belaidi +5 more
wiley +1 more source
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474) +17 more
core +1 more source
ABSTRACT Objective To assess post‐vaccination changes in chemosensory function among individuals with and without COVID‐19‐related chemosensory impairment. Methods In this global, multilingual online survey, participants reported vaccination status, vaccine side effects, and changes in smell and taste before and after each vaccine dose.
Sachiko Koyama +17 more
wiley +1 more source
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474) +17 more
core +1 more source
Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles
PEG‐lipids play a central role in governing lipid nanoparticle stability, targeting, and function. However, PEG‐lipids can “shed” from the nanoparticle surface in biological environments, with the extent and kinetics of shedding influenced by chemical and biological factors.
Ethan P. Cisneros +2 more
wiley +1 more source
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474) +17 more
core +1 more source
Enhancing our comprehension of mRNA vaccines may facilitate the future design of novel vaccines aimed at augmenting immune protection while minimising reactogenic responses. Before this design is carried out, it is important to determine whether adaptive
Joaquín Sáez-Peñataro +6 more
doaj +1 more source
Insights into the potential candidate hub genes may facilitate the generation of safe and effective immunity against seasonal influenza as well as the development of personalized influenza vaccines for the elderly at high risk of influenza virus ...
Jing Yang +17 more
doaj +1 more source

